Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation | Zendy

Matthew Abramson | Zendy; Victoria Gutgarts | Zendy; Junting Zheng | Zendy; Molly Maloy | Zendy; Josel D. Ruiz | Zendy; Michael Scordo | Zendy; Edgar A. Jaimes | Zendy; Insara Jaffer Sathick | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation

Author(s) -

Matthew Abramson,

Victoria Gutgarts,

Junting Zheng,

Molly Maloy,

Josel D. Ruiz,

Michael Scordo,

Edgar A. Jaimes,

Insara Jaffer Sathick

Publication year - 2021

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.19801220

Subject(s) - medicine , stem cell , acute kidney injury , hematopoietic stem cell transplantation , transplantation , haematopoiesis , kidney transplantation , immunology , intensive care medicine , microbiology and biotechnology , biology

AKI is a major complication of allogeneic hematopoietic stem cell transplantation, increasing risk of nonrelapse mortality. AKI etiology is often ambiguous due to heterogeneity of conditioning/graft versus host disease regimens. To date, graft versus host disease and calcineurin inhibitor effects on AKI are not well defined. We aimed to describe AKI and assess pre-/post-hematopoietic transplant risk factors in a large recent cohort.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research